Premium
In silico analysis highlights the copy number variation mechanism responsible for the historically reported VWF exon 42 deletion
Author(s) -
Cartwright A.,
Peake I. R.,
Goodeve A. C.,
Hampshire D. J.
Publication year - 2016
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.13059
Subject(s) - medicine , immunity , disease , immunology , immune system
report and review of literature. J Invasive Cardiol 2004; 16: 330–2. 8 Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A. Management of an acute coronary syndrome in a patient with severe haemophilia A. Haemophilia 2007; 13: 763–5. 9 Smolka G, Kulach A, Dabek J, Szulc A, Gasior Z. Percutaneous coronary intervention with stent implantation in haemophilic A patient with unstable angina. Haemophilia 2007; 13: 428–31. 10 Kim DK, Kim DI, Kim MS et al. Successful percutaneous coronary intervention for acute coronary syndrome in a patient with severe hemophilia A. Korean Circ J 2010; 40: 527–9. 11 Bangalore S, Kumar S, Fusaro M et al. Shortand long-term outcomes with drugeluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 2012; 125: 2873–91. 12 Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Everolimuseluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 2015; 372: 1213–22.